HTG Molecular Diagnostics
HTGM
$0.48
Share price
0.00%
Change (1 day)
-96.26%
Change (1 year)
Categories
HTG Molecular Diagnostics (HTGM) - Net assets
Net assets on the balance sheet as of March 2023 : $0.47 M
According to HTG Molecular Diagnostics
's latest financial reports the company has $0.47 M in net assets.
A company’s net assets is the sum of its assets minus the sum of its liabilities.
HTG Molecular Diagnostics - Net assets on balance sheet (from 2013 to 2023)
Net assets by year
| Year | Net assets | Change |
|---|---|---|
| 2022-12-31 | $5.39 M | -48.16% |
| 2021-12-31 | $10.39 M | -28.2% |
| 2020-12-31 | $14.48 M | -39.57% |
| 2019-12-31 | $23.96 M | 13.64% |
| 2018-12-31 | $21.09 M | -789.39% |
| 2017-12-31 | $-3.06 M | -45.3% |
| 2016-12-31 | $-5.6 M | -133.11% |
| 2015-12-31 | $16.89 M | -170.27% |
| 2014-12-31 | $-24.05 M | 7.09% |
| 2013-12-31 | $-22.45 M | 22.94% |
| 2012-12-31 | $-18.26 M |
Net assets for similar companies or competitors
| Company | Net assets | differencediff. | Country |
|---|---|---|---|
 Lexicon Pharmaceuticals
LXRX | $93.11 M | 19,522.68% | 🇺🇸 USA |
 Affimed
AFMD | $63.91 M | 13,368.94% | 🇩🇪 Germany |
 Calithera Biosciences
CALA | $20.39 M | 4,197.56% | 🇺🇸 USA |